The accessible
strategic markets that KIYATEC is tackling within life science
discovery, biomaterial and pharmaceutical development and clinical
diagnostics have a combined market cap in excess of $1
billion. We believe there is evidence of a substantial
need for advanced three-dimensional cell culture models within
each of these markets to better represent the human condition in
the laboratory.
Discover.
Develop. Diagnose.™ KIYATEC 3D Cell Culture Delivers
